If you liked this article you might like

Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO '17 Meeting
Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More
Kite Pharma Discloses CAR-T Patient Death, Rattling Investors
Former Dendreon CEO Mitch Gold Returns to Public Biotech Stage with Cancer Immunotherapy Merger